Emergency Contraception Market Outlook Through 2030: Understanding The Growth Opportunity
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Emergency Contraception Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The emergency contraception market size has experienced robust expansion in recent years. Its projected expansion is from $1.55 billion in 2025 to $1.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth in previous periods include heightened awareness regarding emergency contraception, an increase in contraceptive failure rates, wider reach of retail pharmacy networks, an escalating need for hormonal contraceptives, and successful regulatory approvals for emergency contraceptive pills.
The emergency contraception market is projected to experience substantial expansion over the upcoming years. Its size is anticipated to reach $2.16 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is attributable to factors such as the increasing uptake of online pharmacy platforms, a rising need for homecare delivery solutions, the development of awareness programs tailored to specific age groups, a growing inclination towards non-hormonal and herbal options, and the launch of products with higher doses and multiple formulations. Key trends expected over this period involve the greater accessibility of over-the-counter emergency contraceptives, a surge in the use of online pharmacies and home delivery services, an enhanced emphasis on awareness initiatives targeting adolescents and adults, the broader availability of high-dose and multi-formulation choices, and increased incorporation of copper intrauterine devices and non-hormonal approaches.
Get A Free Sample Report With In-Depth Market Insights:
Emergency Contraception Market Growth Drivers: What’s Behind The Acceleration?
The escalating incidence of unprotected intercourse is anticipated to stimulate the expansion of the emergency contraception market moving ahead. Unprotected intercourse is defined as sexual activity performed without utilizing any type of barrier contraception, such as condoms, or other dependable birth control methods, which places participants at risk for unwanted pregnancies and sexually transmitted infections. The rise in unprotected intercourse is attributed to decreasing condom usage and inconsistent adoption of other contraceptive practices among sexually active individuals, especially young adults and adolescents, which consequently increases the probability of unprotected sexual encounters. Emergency contraception offers a crucial backup option after unprotected intercourse by preventing unintended pregnancies, directly addressing the outcomes of forgotten or absent contraception, and reducing the immediate danger associated with unprotected sexual activity. For example, according to the 2023 National Youth Risk Behavior Survey conducted by the Centers for Control and Prevention, a US-based government agency, in a 2023 survey of U.S. high school students, 32% reported having engaged in sexual intercourse at least once, and 48% indicated they did not use a condom during their most recent sexual encounter. Therefore, the growing rates of unprotected intercourse are fueling the growth of the emergency contraception market.
Emergency Contraception Market Segment Analysis And Revenue Potential
The emergency contraception market covered in this report is segmented –
1) By Product Type: Levonorgestrel, Ulipristal Acetate, Mifepristone, Other Product Types
2) By Dosage Form: Tablets, Injections, Other Dosage Forms
3) By Age Group: Adolescents, Adults
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
5) By End-User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Levonorgestrel: Single Dose Tablets, Two Dose Tablets, Over The Counter Formulations, Prescription Based Formulations
2) By Ulipristal Acetate: Single Dose Tablets, Prescription Based Tablets, High Dose Formulations, Low Dose Formulations
3) By Mifepristone: Low Dose Emergency Use, Combination Regimen Formulations, Prescription Based Tablets, Clinical Setting Formulations
4) By Other Product Types: Copper Intrauterine Devices, Combined Hormonal Regimens, Non Hormonal Methods, Herbal Based Formulations
Emergency Contraception Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the emergency contraception market are concentrating on developing innovative products, such as over-the-counter emergency contraceptives, to enhance accessibility and offer swift, effective pregnancy prevention. Over-the-counter emergency contraceptives are oral tablets containing hormones like levonorgestrel that can be acquired without a prescription and assist in preventing pregnancy by postponing ovulation or fertilization when taken shortly after unprotected sexual activity. For instance, in August 2024, Verséa Health Inc., a US-based healthcare company specializing in diagnostics and consumer health solutions, introduced empowered choice, a U.S. Food and Drug Administration–approved over‑the‑counter emergency contraceptive intended to expand accessible options through mainstream retail and online channels. The introduction involved nationwide distribution agreements with major pharmacies and e-commerce platforms, alongside a comprehensive educational campaign designed to increase awareness regarding emergency contraception choices, correct usage, and optimal timing for effectiveness. This initiative aimed to reach a broader audience, lessen the stigma surrounding emergency contraception, and ensure individuals could obtain the product rapidly and discreetly. The product utilizes a simple oral levonorgestrel formulation that guarantees effective emergency pregnancy prevention, is available without a prescription, and grants individuals greater autonomy and flexibility in making reproductive health decisions.
Emergency Contraception Market Leading Players And Competitive Positioning
Major companies operating in the emergency contraception market are Pfizer Inc.; Bayer Aktiengesellschaft, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Amneal Pharmaceuticals Inc., Lupin Limited, Gedeon Richter Plc, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Mankind Pharma Limited, Piramal Pharma Limited, CooperSurgical Inc., HLL Lifecare Limited, Zhejiang Xianju Pharmaceutical Co. Ltd., AdvaCare Pharma, Afaxys Inc., Syzygy Healthcare Solutions, Foundation Consumer Healthcare, Shanghai Dahua Pharmaceutical Co. Ltd.
View The Full Emergency Contraception Market Report:
Emergency Contraception Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the emergency contraception market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emergency contraception market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.